← back to search

Gui‐Qi Zhu

Ministry of Education of the People's Republic of China · CN
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cancer-related molecular mechanisms research, and RNA modifications and cancer.
h-index
30
citations
2,745
works
95
NIH funding
primary concept
email

Recent publications

Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma
Nature Communications 2025cited by 23position: middledoi
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
Signal Transduction and Targeted Therapy 2025cited by 15position: firstdoi
Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti‐PD‐1 therapy in hepatocellular carcinoma
Cancer Communications 2024cited by 136position: middledoi
Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma
Cellular and Molecular Immunology 2024cited by 30position: middledoi
Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy
Science Advances 2023cited by 140position: middledoi
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
Hepatology International 2023cited by 55position: middledoi
Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy
Oncogene 2023cited by 39position: middledoi
Single-cell and spatial architecture of primary liver cancer
Communications Biology 2023cited by 34position: middledoi
Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
Journal of Translational Medicine 2023cited by 32position: middledoi
Multiomics analysis reveals metabolic subtypes and identifies diacylglycerol kinase α (DGKA) as a potential therapeutic target for intrahepatic cholangiocarcinoma
Cancer Communications 2023cited by 17position: middledoi
Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer
BMC Cancer 2022cited by 23position: middledoi
Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1
Journal of Experimental & Clinical Cancer Research 2021cited by 115position: middledoi
Splicing factors: Insights into their regulatory network in alternative splicing in cancer
Cancer Letters 2020cited by 74position: middledoi
Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications
Cancer Immunology Immunotherapy 2020cited by 35position: middledoi
The miR-561-5p/CX<sub>3</sub>CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX<sub>3</sub>CR1<sup>+</sup> Natural Killer Cells Infiltration
Theranostics 2019cited by 147position: middledoi
Comparative efficacy and safety between ablative therapies or surgery for small hepatocellular carcinoma: a network meta-analysis
Expert Review of Gastroenterology & Hepatology 2018cited by 49position: firstdoi
Clinical features of macrophage activation syndrome in the adult northern Chinese population
Lupus 2014cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jia Fan · China Medical University10 papers (2018–2025)Ying‐Hong Shi · Cancer Institute (WIA)9 papers (2018–2025)Wei‐Feng Qu · Ministry of Education of the People's Republic of China7 papers (2023–2025)Jian Zhou · Ministry of Education of the People's Republic of China6 papers (2023–2025)Zheng Tang · Ruijin Hospital6 papers (2023–2025)Zhi Dai · Fudan University5 papers (2018–2025)Chenyang Tao · Guangzhou University of Chinese Medicine5 papers (2023–2025)Run Huang · University of Southern California5 papers (2023–2025)Wei‐Ren Liu · Chung Yuan Christian University5 papers (2023–2025)Yuan Fang · Fudan University4 papers (2023–2025)Meng‐Xin Tian · Sun Yat-sen University4 papers (2023–2025)Xi‐Fei Jiang · Sun Yat-sen University4 papers (2023–2023)Jun-Xian Du · Sun Yat-sen University4 papers (2020–2024)Jian Zhou · Shenzhen University Health Science Center3 papers (2018–2023)Jialiang Cai · Fudan University3 papers (2020–2025)Jun Gao · Fudan University3 papers (2023–2025)Weiren Liu · Ministry of Education of the People's Republic of China3 papers (2023–2025)Jing-Lei Wan · Fudan University3 papers (2021–2024)Tian-Hao Chu · Fudan University3 papers (2023–2025)Shiping Chen · Shandong Academy of Pharmaceutical Sciences3 papers (2021–2025)